Jinling Pharmaceutical Company Limited (SHE:000919)
China
· Delayed Price · Currency is CNY 6.95
-0.02 (-0.29%)
Jul 4, 2025, 2:45 PM CST
SHE:000919 Revenue
Jinling Pharmaceutical Company had revenue of 810.01M CNY in the quarter ending March 31, 2025, a decrease of -4.25%. This brings the company's revenue in the last twelve months to 3.25B, down -2.58% year-over-year. In the year 2024, Jinling Pharmaceutical Company had annual revenue of 3.28B with 2.74% growth.
Revenue (ttm)
3.25B
Revenue Growth
-2.58%
P/S Ratio
1.34
Revenue / Employee
560.63K
Employees
5,789
Market Cap
4.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.28B | 87.45M | 2.74% |
| Dec 31, 2023 | 3.19B | 523.03M | 19.58% |
| Jan 1, 2023 | 2.67B | -137.79M | -4.91% |
| Jan 1, 2022 | 2.81B | 305.02M | 12.18% |
| Dec 31, 2020 | 2.50B | -31.19M | -1.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |